Beech Hill Advisors Inc. Acquires 162 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Beech Hill Advisors Inc. raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,655 shares of the exchange traded fund’s stock after acquiring an additional 162 shares during the quarter. Beech Hill Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $599,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in XBI. Hartline Investment Corp raised its position in SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after purchasing an additional 106 shares during the last quarter. Signature Estate & Investment Advisors LLC increased its stake in shares of SPDR S&P Biotech ETF by 5.7% in the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock valued at $231,000 after buying an additional 125 shares during the period. Denver Wealth Management Inc. raised its holdings in SPDR S&P Biotech ETF by 0.9% in the 3rd quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock valued at $1,460,000 after buying an additional 127 shares during the last quarter. Resources Management Corp CT ADV boosted its position in SPDR S&P Biotech ETF by 30.3% during the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after buying an additional 138 shares during the period. Finally, Trust Co. of Vermont grew its holdings in SPDR S&P Biotech ETF by 4.7% during the 3rd quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock worth $302,000 after acquiring an additional 138 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.5 %

NYSEARCA XBI traded down $0.42 on Thursday, hitting $88.13. The company’s stock had a trading volume of 648,060 shares, compared to its average volume of 8,958,191. The company’s 50-day moving average is $94.72 and its 200 day moving average is $97.00. The firm has a market cap of $6.72 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.